Medicare Enrolled
Dr. Jerome Kane, M.D.
Neurology · Bedford, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kane? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kane
Dr. Jerome Kane is a neurology in Bedford, TX, with 20 years in practice. Based on federal Medicare data, Dr. Kane performed 27,606 Medicare services across 1,905 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kane received a total of $24,742 from 94 pharmaceutical and/or device companies across 1340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kane is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 3% volume in TX$ $24,742 industry payments
Medicare Practice Summary
Medicare Utilization ↗27,606
Medicare services
Top 3% in TX for neurology
1,905
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,380 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 24,480 | $18 | $30 |
| Hospital follow-up visit, moderate complexity | 634 | $62 | $105 |
| Hospital follow-up visit, low complexity | 576 | $38 | $65 |
| Office visit, established patient (30-39 min) | 507 | $89 | $195 |
| Drug injection, under skin or into muscle | 427 | $11 | $40 |
| Injection, zoledronic acid, 1 mg | 260 | $6 | $130 |
| New patient office visit (45-59 min) | 114 | $122 | $260 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 111 | $47 | $180 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 97 | $77 | $150 |
| Initial hospital admission, high complexity | 78 | $136 | $300 |
| Initial hospital admission, moderate complexity | 56 | $98 | $200 |
| Hospital discharge management, 30+ min | 55 | $89 | $175 |
| EEG, extended monitoring | 53 | $343 | $650 |
| Office visit, established patient (20-29 min) | 43 | $62 | $145 |
| Hospital discharge day management, 30 minutes or less | 30 | $63 | $140 |
| Nerve conduction, 9-10 studies | 28 | $167 | $322 |
| Telephone medical discussion with physician, 5-10 minutes | 21 | $33 | $85 |
| New patient office visit, complex (60-74 min) | 18 | $135 | $300 |
| Office visit, established patient, complex (40-54 min) | 18 | $139 | $239 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
91.4% medium
8.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,742
Total received (2018-2024)
Avg $3,535/year across 7 years
Top 15% in TX for neurology
94
Companies
1,340
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,250 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$492 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,438
2023$4,392
2022$2,999
2021$2,768
2020$2,744
2019$4,250
2018$4,151
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$3,177
ABBVIE INC.
$2,251
Novartis Pharmaceuticals Corporation
$1,461
Allergan, Inc.
$984
Biogen, Inc.
$917
Lilly USA, LLC
$843
ACADIA Pharmaceuticals Inc
$760
UCB, Inc.
$747
Allergan Inc.
$669
PFIZER INC.
$635
Amgen Inc.
$522
GENZYME CORPORATION
$520
Merz Pharmaceuticals, LLC
$494
AbbVie, Inc.
$432
Alnylam Pharmaceuticals Inc.
$426
JAZZ PHARMACEUTICALS INC.
$405
Biohaven Pharmaceuticals, Inc.
$402
AbbVie Inc.
$394
Adamas Pharmaceuticals, Inc.
$372
Celgene Corporation
$365
SK Life Science, Inc.
$351
Alexion Pharmaceuticals, Inc.
$342
EMD Serono, Inc.
$333
Janssen Pharmaceuticals, Inc
$332
US WorldMeds, LLC
$319
LivaNova USA, Inc.
$315
Acorda Therapeutics, Inc
$280
IMPEL PHARMACEUTICALS INC.
$279
Neurocrine Biosciences, Inc.
$267
Horizon Therapeutics plc
$245
Genentech USA, Inc.
$233
Grifols USA, LLC
$214
Lundbeck LLC
$204
Harmony Biosciences LLC
$202
Axsome Therapeutics, Inc.
$197
Sunovion Pharmaceuticals Inc.
$176
Eisai Inc.
$174
Octapharma USA, Inc.
$153
Scilex Pharmaceuticals Inc.
$147
Penumbra, Inc.
$147
ARGENX US, INC.
$136
GE HealthCare
$134
Avanir Pharmaceuticals, Inc.
$134
Supernus Pharmaceuticals, Inc.
$126
TG THERAPEUTICS, INC.
$125
E.R. Squibb & Sons, L.L.C.
$119
Avadel CNS Pharmaceuticals, LLC
$117
Otsuka America Pharmaceutical, Inc.
$113
CSL Behring
$111
Corium, LLC
$109
UPSHER-SMITH LABORATORIES LLC
$102
Ipsen Biopharmaceuticals, Inc
$98
Biohaven Pharmaceutical Holding Company Ltd.
$97
Amylyx Pharmaceuticals, Inc.
$88
Takeda Pharmaceuticals U.S.A., Inc.
$85
GE HEALTHCARE
$82
MITSUBISHI TANABE PHARMA AMERICA, INC.
$78
Boston Scientific Corporation
$77
Akcea Therapeutics, Inc.
$70
GRT US Holding, Inc.
$63
Amneal Pharmaceuticals LLC
$62
Vertiflex, Inc.
$57
Upsher-Smith Laboratories LLC
$55
Avion Pharmaceuticals
$53
HARMONY BIOSCIENCES LLC
$47
BOSTON SCIENTIFIC CORPORATION
$44
Currax Pharmaceuticals LLC
$42
Banner Life Sciences, LLC
$42
ARBOR PHARMACEUTICALS, INC.
$42
Assertio Therapeutics, Inc.
$41
Jazz Pharmaceuticals Inc.
$39
Abbott Laboratories
$39
Avanos Medical
$36
Mallinckrodt Enterprises LLC
$29
Averitas Pharma Inc.
$28
SCILEX PHARMACEUTICALS INC.
$25
Promius Pharma LLC
$25
MERZ NORTH AMERICA, INC.
$24
Kyowa Kirin, Inc.
$23
Exeltis, USA Inc.
$20
EISAI INC.
$20
BANNER LIFE SCIENCES, LLC
$19
Silk Road Medical, Inc.
$19
NS Pharma, Inc.
$19
Almatica Pharma LLC
$17
Catalyst Pharmaceuticals, Inc.
$17
Mallinckrodt Hospital Products Inc.
$16
Sumitomo Pharma America, Inc.
$16
Vertical Pharmaceuticals, LLC
$15
Nevro Corp.
$14
AstraZeneca Pharmaceuticals LP
$13
AQUESTIVE THERAPEUTICS, INC.
$13
Xeris Pharmaceuticals, Inc.
$12
Strongbridge US INC.
$12
Top 3 companies account for 27.8% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX - NEUROLOGY · BOTOX - SPASTICITY · BOTOX COSMETIC · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · CAMBIA · CONTRAVE · COOLIEF* COOLED RADIOFREQUENCY · COPAXONE · Cambia · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · EMGALITY · ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter · EVENITY · FABRAZYME · FIRDAPSE · Fycompa · GAMMAGARD · GENERAL DBS · GENERAL DBS · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · GVOKE PFS · Gamunex-C · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INVOKANA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LUMRYZ · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · Ocrevus · Ongentys · PANZYGA · PLEGRIDY · PURIFIED CORTROPHIN GEL · Penumbra System · Ponvory · Proclaim Family of SCS IPGs · Prolia · QULIPTA · QUTENZA · Qutenza · RADICAVA · RELYVRIO · REXULTI · RYTARY · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SUNOSI · SYMPAZAN · Senza · Skyclarys · Soliris · Sunosi · Superion ISS · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VERCISE · VILTEPSO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XARELTO · XCOPRI · XEOMIN · XYREM · XYWAV · Xadago · Xeomin · Xyrem · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIPSOR · ZTLido · Zembrace · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $90 per 100 Medicare services performed
Geographic Context
Neurologys within 10 mi
249
Per 100K population
11.7
County median income
$81,905
Nearest hospital
TEXAS HEALTH HARRIS METHODIST HURST-EULESS-BEDFORD
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kane is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (low-engagement, top 15%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kane experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Kane performed 24,480 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kane receive payments from pharmaceutical companies?
Yes. Dr. Kane received a total of $24,742 from 94 companies across 1,340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kane's costs compare to other neurologys in Bedford?
Dr. Kane's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologys in Bedford
Browse neurologys in Bedford ranked by procedure volume and transparency data.
Highest volume
Top Neurologys in TX
Neurologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologys in TX
Which TX neurologys receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc..
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology